Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06328374

Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease

Prevalence and Detection of Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
60 Years – 100 Years
Healthy volunteers
Accepted

Summary

This research study is investigating whether people with Alzheimer's disease experience more changes to voice and swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe Alzheimer's Disease is high (85-93%) and voice is also often negatively impacted by Alzheimer's disease. The overall objective of this study is to evaluate the voice and swallowing function of adults with and without Alzheimer's disease. The investigators will also be involving the primary caregivers of individuals with Alzheimer's that are enrolled in the study to better understand the impact of voice and swallowing impairments on the primary caregivers of those with Alzheimer's Disease. Healthy adults and individuals with Alzheimer's disease will: * undergo tests of cough, voice, and swallow function * undergo tests of grip and tongue strength * complete questionnaires Caregivers of individuals with Alzheimer's disease will also complete questionnaires.

Detailed description

This study will involve one in-person research visit that will last approximately 1-1.5 hours and will consist of a screening, cough testing, swallow function testing, vocal function testing, assessments of hand grip and tongue strength, and completion of questionnaires. Caregivers of those with Alzheimer's disease will also complete questionnaires at this initial visit. Following the first research evaluation visit, individuals will be contacted via email or by phone annually for two consecutive years to complete the same questionnaires completed at the initial visit.

Conditions

Timeline

Start date
2024-11-05
Primary completion
2024-11-05
Completion
2024-11-05
First posted
2024-03-25
Last updated
2024-11-07

Source: ClinicalTrials.gov record NCT06328374. Inclusion in this directory is not an endorsement.